中文

IMP — Vietnamese Stock News

14 published articles · IMP

14 Articles
Recent News
Imexpharm (IMP) Appoints Chinese Chairman After Livzon's $240M Acquisition

Imexpharm (IMP) names Liu Daping as Chairman after Livzon completes 67.8% stake acquisition for VND 6,000B, marking a major M&A in Vietnam pharma.

2026-07-01
Imexpharm (IMP) Board Reshuffles After Livzon's 67.87% Stake Acquisition

Imexpharm (IMP) board members resign after Livzon Pharmaceutical Group acquires 67.87% stake. AGG and OCB also announce leadership changes.

2026-05-22
Three Imexpharm Board Members Resign After Livzon Unit Acquires 67.87% Stake

Three IMP board members resign after Lian SGP Holding, a Livzon subsidiary, acquires 67.87% of Imexpharm for ~VND 6,000B (USD 240M).

2026-05-20
Imexpharm (IMP) Chairman and Two Board Members Resign After Livzon Takeover

Imexpharm (IMP) Chairman Woo Sungmin and two board members resign on May 18, 2026, following Chinese pharma Livzon's acquisition of 67.87% stake.

2026-05-20
SK Group Exits Imexpharm (IMP) with 2x Return; Livzon Acquires 67.87% Stake

SK Group sells 61.8% of Imexpharm for ~$200M, doubling its investment. Livzon Pharmaceutical acquires 67.87% of IMP for VND 6,000B.

2026-05-18
Livzon Group Acquires 67.87% of Imexpharm (IMP) from SK for VND 6,000B

China's Livzon Pharmaceutical buys 67.87% of Imexpharm (IMP) from SK Group for ~VND 6,000B. IMP reports 2025 revenue up 16%, pre-tax profit up 10.4%.

2026-05-15
Chinese Livzon Acquires 67.87% of Imexpharm (IMP) for VND 6,000B in Landmark Pharma M&A

Livzon Pharmaceutical Group acquires 67.87% of Imexpharm (IMP) for ~VND 6,000B. Deal highlights foreign control trend in Vietnam's pharma sector.

2026-05-13
Imexpharm (IMP) Leaders Sell Shares After Livzon Group Acquires 67.87% Stake

Imexpharm (IMP) leaders sell shares after Livzon Group acquires 67.87% stake for ~$240M. Deal shifts control from SK Group to Chinese pharma giant.

2026-05-13
Imexpharm (IMP) Leaders Sell Shares as Lian SGP Acquires 67.87% Stake from SK Group

Imexpharm (IMP) leaders sold shares on May 7 as Lian SGP Holding bought a 67.87% stake from SK Group for nearly VND 6,000B, becoming the new parent company.

2026-05-13
Livzon Acquires 67.87% Stake in Imexpharm (IMP) for $240M

Chinese pharma Livzon buys 67.87% of Imexpharm (IMP) for VND 6,000B ($240M), gaining control of Vietnam's top antibiotic maker.

2026-05-12
Chinese Giant Livzon Acquires 67.87% of Imexpharm (IMP) for $240M

Livzon subsidiary Lian SGP buys 67.87% of Imexpharm (IMP) for ~VND 6,000B ($240M), becoming the parent company of the leading Vietnamese pharma firm.

2026-05-12
Chinese Pharma Livzon Acquires 67.87% Stake in Imexpharm (IMP) for VND 6,000B

Livzon unit Lian SGP buys 67.87% of Imexpharm (IMP) at VND 57,400/share, becoming majority holder. SK Group entities and IMP leaders register to sell shares.

2026-05-01
Livzon Pharmaceutical Acquires 67.87% Stake in Imexpharm (IMP) for VND 6,000 Billion

Chinese pharma giant Livzon acquires 67.87% of Imexpharm (IMP) via tender offer at VND 57,400/share, totaling ~VND 6,000 billion (USD 240 million).

2026-05-01
Imexpharm (IMP) Executives Register to Sell Shares for Personal Financial Planning

Imexpharm (IMP) CEO and two Deputy CEOs register to sell 607,400 shares from mid-April to mid-May 2026, citing personal financial reasons. The HoSE-listed pharmaceutical firm targets record 2026 revenue of VND 3,200B.

2026-04-15
Explore
IMP full analysis All stocks All sectors

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-10-30T20:51:37.485316.